2 Results Sort by:
rGIFT15: Recombinant Fusion Protein for the Treatment of Autoimmune Diseases
Application Recombinant fusion protein comprising GM-CSF and interleukin-15 for treating autoimmune diseases. Key Benefits rGIFT15 lacks any post-translation modification such as glycosylation. Market Summary For those suffering from autoimmune diseases current therapies treat the symptoms, but do not provide a cure and currently available immunosuppressant...
Published: 7/28/2023       Contributor(s): Jacques Galipeau, Andrea Pennati
Recombinant Manufacturing Process for GIFT Fusion Cytokines
Application A prokaryotic manufacturing process for efficient production of recombinant GIFT (GM-CSF & Interleukin Fusion Transgene) fusion cytokines as well as other recombinant therapeutics. Key Benefits Production via bacterial and yeast expression increases yield 1000 fold compared to mammalian systems while also decreasing cost and complexity. GIFTs...
Published: 4/23/2024       Contributor(s): Jacques Galipeau, Andrea Pennati